Analysts Set Verona Pharma plc (NASDAQ:VRNA) Target Price at $81.50
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine brokerages that are presently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month […]
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine brokerages that are presently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month […]
